Blueprint Medicines Corp logo

BPMC

Blueprint Medicines Corp

$97.62

Earnings Summary

Revenue
$128.18Mn
Net Profits
$-56.28Mn
Net Profit Margins
-43.9%

Highlights

Revenue:

Blueprint Medicines Corp’s revenue jumped 126.61% since last year same period to $128.18Mn in the Q3 2024. On a quarterly growth basis, Blueprint Medicines Corp has generated -7.22% fall in its revenue since last 3-months.

Net Profits:

Blueprint Medicines Corp’s net profit jumped 57.91% since last year same period to $-56.28Mn in the Q3 2024. On a quarterly growth basis, Blueprint Medicines Corp has generated -12.57% fall in its net profits since last 3-months.

Net Profit Margins:

Blueprint Medicines Corp’s net profit margin jumped 81.43% since last year same period to -43.9% in the Q3 2024. On a quarterly growth basis, Blueprint Medicines Corp has generated -21.32% fall in its net profit margins since last 3-months.

Earnings per share (EPS) Estimates

Earnings per share (EPS) estimates of the Blueprint Medicines Corp post its latest quarter earnings

EPS Estimate Current Year
-1.66

Highlights

EPS Estimate Current Year:

Blueprint Medicines Corp’s earning per share (EPS) estimates for the current year stand at -1.66.

Key Ratios

Key ratios of the Blueprint Medicines Corp post its Q3 2024 earnings

Earning Per Share (EPS)
-0.89

Highlights

Earning Per Share (EPS):

Blueprint Medicines Corp’s earning per share (EPS) jumped 59.55% since last year same period to -0.89 in the Q3 2024. This indicates that the Blueprint Medicines Corp has generated 59.55% annual rate of jump in its earning per share (EPS) in the last 4 quarters.

Earnings Calendar

Earnings DateEstimated EPSReported EPSSurprise %
2024-05-02
-1.66
1.4
184.34%
2024-08-01
-1.29
-0.8
37.98%
2024-10-30
-0.97
-0.89
8.25%